Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN72331452Phase 3Terminated
Phase 3, randomised trial in influenza comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Admission to intensive care unit or death within 30 days of hospital admission. Started Aug 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN72331452.